Apkacef T 250mg/31.25mg Injection
Marketer
Apkavit Lifesciences
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Apkacef T 250mg/31.25mg Injection
Ceftazidime/Sulbactam 250mg/31.25mg Injection is a dual-action antibiotic. It's indicated for treating diverse bacterial infections by inhibiting microbial growth and propagation. This injection must be administered only by or under the direct supervision of a qualified healthcare provider. Complete the prescribed treatment regimen; premature cessation may compromise its effectiveness. Report any missed appointments immediately. Common adverse reactions include nausea, vomiting, diarrhea, and dyspepsia. Severe or worsening side effects necessitate prompt medical attention. Seek immediate medical help for allergic reactions like rash, itching, swelling, or breathing difficulties. Inform your physician of all current medications, including over-the-counter drugs, before commencing treatment. Pregnant or lactating individuals should consult their doctor. Alcohol consumption should be avoided due to the risk of increased drowsiness. While it typically doesn't impair driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and sufficient hydration will aid recovery. Your doctor may order laboratory tests to monitor treatment response.
Uses of Apkacef T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Apkacef T 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Apkacef T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Apkacef T 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Apkacef T 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam injection (Apkacef T 250mg/31.25mg) combines the antibiotic Ceftriaxone with the beta-lactamase inhibitor Tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Tazobactam counteracts bacterial resistance mechanisms, thus optimizing Ceftriaxone's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Apkacef T 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Apkacef T 250mg/31.25mg Injection is generally deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; however, clinical data from human trials are scarce.
Breast feedingCAUTION
The injection Apkacef T 250mg/31.25mg requires careful use while breastfeeding. Mothers should discontinue breastfeeding throughout treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Apkacef T 250mg/31.25mg Injection might induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Apkacef T 250mg/31.25mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Apkacef T 250mg/31.25mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. Consult a physician for guidance. Dosage alteration for Apkacef T 250mg/31.25mg Injection is not advised for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Apkacef T 250mg/31.25mg Injection :
Omitting a scheduled dose of Apkacef T 250mg/31.25mg Injection warrants immediate physician consultation.
Facts to Know About Apkacef T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Infectious Disease Treatments |
3,018 People bought this recently